Castle Biosciences, Inc.
CSTL
$24.06
$0.502.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.28% | -6.13% | 4.77% | 7.74% | 8.56% |
| Total Receivables | -6.39% | 11.20% | 1.90% | 9.29% | 7.70% |
| Inventory | 22.15% | -15.81% | 23.78% | -17.98% | 4.81% |
| Prepaid Expenses | 6.00% | 36.03% | -5.92% | 21.41% | 7.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -0.21% | -2.99% | 4.46% | 7.61% | 8.33% |
|
|
|||||
| Total Current Assets | -0.21% | -2.99% | 4.46% | 7.61% | 8.33% |
| Net Property, Plant & Equipment | 34.51% | 6.19% | 11.40% | 11.99% | 12.02% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.01% | -0.01% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.01% | -0.01% |
| Total Other Intangibles | 39.01% | -29.65% | -4.35% | -2.22% | -2.15% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.72% | 5.59% | -26.93% | -22.87% | 37.18% |
| Total Assets | 8.57% | -5.56% | 3.24% | 5.59% | 6.28% |
|
|
|||||
| Total Accounts Payable | 55.03% | 23.20% | 1.34% | -28.62% | 2.38% |
| Total Accrued Expenses | 30.95% | -38.57% | 10.25% | 26.56% | 34.07% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.06% | 24.56% | 17.13% | 42.33% | 3.11% |
| Total Finance Division Other Current Liabilities | 24.88% | 40.19% | 173.28% | -32.98% | 24.67% |
| Total Other Current Liabilities | 24.88% | 40.19% | 173.28% | -32.98% | 24.67% |
| Total Current Liabilities | 36.53% | -24.53% | 11.51% | 12.27% | 23.45% |
|
|
|||||
| Total Current Liabilities | 36.53% | -24.53% | 11.51% | 12.27% | 23.45% |
| Long-Term Debt | -9.25% | -8.46% | -2.70% | 0.07% | 0.08% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 79.04% | -1.90% | -2.16% | 7.33% | 0.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 452.69% | -47.92% | -61.92% | -- | -- |
| Total Liabilities | 45.50% | -18.56% | 2.57% | 15.91% | 13.16% |
|
|
|||||
| Common Stock & APIC | 1.60% | 1.59% | 0.84% | 2.24% | 2.02% |
| Retained Earnings | 2.00% | -12.92% | 4.57% | 1.07% | 4.04% |
| Treasury Stock & Other | -70.23% | -43.04% | -51.37% | 375.00% | -54.95% |
| Total Common Equity | 3.42% | -3.41% | 3.35% | 4.05% | 5.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.42% | -3.41% | 3.35% | 4.05% | 5.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.42% | -3.41% | 3.35% | 4.05% | 5.32% |
|
|
|||||